Read the full article here.
This content was originally published by IoL Business Report. Original publishers retain all rights. It appears here for a limited time before automated archiving. By IoL Business Report
Sanofi SA and partner Regeneron Pharmaceuticals Inc have started a clinical trial of their rheumatoid arthritis drug Kevzara as a treatment for the coronavirus.